Immunotherapy for Bone and Soft Tissue Sarcomas - Test2 - elhamkhani - TriplyDB

Immunotherapy for Bone and Soft Tissue Sarcomas

Immunotherapy for Bone and Soft Tissue Sarcomas

http://www.wikidata.org/entity/Q28088363

about

Deciphering signaling networks in osteosarcoma pathobiology.Managing sarcoma: where have we come from and where are we going?

P2860

Q37106930-51FE6C21-34D7-42C9-ADE2-6315E2FB0FB1 Q41988197-BF9F2BF1-7113-43F2-8848-125CB7CBBB55

P2860

Immunotherapy for Bone and Soft Tissue Sarcomas

http://www.wikidata.org/entity/Q28088363

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Immunotherapy for Bone and Soft Tissue Sarcomas

@ast

Immunotherapy for Bone and Soft Tissue Sarcomas

@en

Immunotherapy for Bone and Soft Tissue Sarcomas

@nl

type

label

Immunotherapy for Bone and Soft Tissue Sarcomas

@ast

Immunotherapy for Bone and Soft Tissue Sarcomas

@en

Immunotherapy for Bone and Soft Tissue Sarcomas

@nl

prefLabel

Immunotherapy for Bone and Soft Tissue Sarcomas

@ast

Immunotherapy for Bone and Soft Tissue Sarcomas

@en

Immunotherapy for Bone and Soft Tissue Sarcomas

@nl

P1433

Q28088363-60C9D684-A05B-4579-A311-97556965E0EF

P1476

Q28088363-55BEFAE5-E462-42B2-ABBF-FA63D0B4E494

P2093

Q28088363-5693A132-F368-432A-B013-C2258B28034E

Q28088363-6BE4E798-05E6-4F13-B30B-19DB26AC620C

Q28088363-6DAF3ED8-16AD-4A2C-982E-5EDB1E00FF3A

Q28088363-6E3B5BC5-AA3D-4AEE-8BB3-C26F5E0802DF

Q28088363-FCC60A90-0F37-4A34-A956-6B4FD8D45D71

P275

Q28088363-9D5BD116-F6FB-4E65-80A4-708C207101EC

P2860

Q28088363-016C1A43-9924-4E8A-96F7-AA118D7FA08E

Q28088363-01B8ECEA-4AE5-4BEE-9619-23AD4531A962

Q28088363-055F88E2-71D1-43A4-B7CC-B82B7FC87E0B

Q28088363-09334700-96F5-48EB-B12D-0097F0D6C0B4

Q28088363-0C275317-032B-43F5-9D38-978451196664

Q28088363-0C87813A-E552-45E5-B9B5-312864F8C059

Q28088363-0D23A672-F573-4F3C-80F5-A64B2107EB40

Q28088363-0F09F339-35F9-4633-9C65-A811A92A81DE

Q28088363-116B56D5-360F-46FA-8351-8340D76D6358

Q28088363-11918353-2DAB-4059-B50D-52F962406158

P304

Q28088363-B77B54E2-3ABB-4E5D-81EB-CC0BEE69B0F3

P31

Q28088363-2969E72C-BD32-40A9-8229-923618277416

Q28088363-2B5EF54F-B451-46F4-8310-6E152C4E22AC

P356

Q28088363-A07F634A-B0B5-437C-8487-273FCBCB0969

P407

Q28088363-6160115A-7793-437D-8476-9A5736423297

P478

Q28088363-FA4E8B8F-0B14-4ECF-8E68-277D388F22AB

P50

Q28088363-B12C4804-F21D-4FF6-91F3-FC41A7F78211

P5008

Q28088363-DAFECA79-A918-4A0D-BC19-FF0FD19C3801

P577

Q28088363-6E3D7832-B7A9-49FC-B014-5C4F822A15FF

Q28088363-9A89D3A3-DF07-464C-A72C-B0744ED7E67F

P5875

Q28088363-FCDD6332-F622-4DC5-9E51-890899EBF6E3

P698

Q28088363-3E536288-12C4-4775-A788-E94D46F8ACAA

P921

Q28088363-3A0160A3-ACFD-4203-AD9A-279CC3E22955

Q28088363-4420A652-36F2-4383-A385-2F2DA7DA109F

Q28088363-45899978-ED2E-4152-A3F6-0495B28AECB8

Q28088363-67DA0ED3-D1FA-40A6-9B85-D92968967019

Q28088363-CFC2775F-6DC5-468E-B06B-F721B2988574

Q28088363-DD1D0B44-260A-4D99-A49F-259BE2C2FE37

Q28088363-EE9287FB-5C21-43D2-8AC9-C0A742D357AD

P932

Q28088363-7B5ED012-F519-4DEE-863A-16EDA6E33782

P356

P1433

BioMed Research International

P1476

Immunotherapy for Bone and Soft Tissue Sarcomas

@en

P2093

Heiichiro Udono

http://www.w3.org/2001/XMLSchema#string

Ken Takeda

http://www.w3.org/2001/XMLSchema#string

Tomohiro Fujiwara

http://www.w3.org/2001/XMLSchema#string

Toshifumi Ozaki

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Kunisada

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

The epidemiology of sarcoma

Immunotherapy for advanced renal cell cancer

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Adoptive immunotherapy for cancer: building on success

Cancer immunotherapy: moving beyond current vaccines

TLR signaling pathways

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

P304

820813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/820813

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Takenori Uehara

P5008

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280060075

http://www.w3.org/2001/XMLSchema#string

P698

26167500

http://www.w3.org/2001/XMLSchema#string

P921

epithelioid sarcoma

neoplasm, connective and soft tissue

soft-tissue sarcoma

P932

4488089

http://www.w3.org/2001/XMLSchema#string